Stock 2480 BEIJING LUZHU BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Beijing Luzhu Biotechnology Co., Ltd.

Equities

2480

CNE100005YD8

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:14 2024-06-11 am EDT 		5-day change 1st Jan Change
19.64 HKD -0.71% Intraday chart for Beijing Luzhu Biotechnology Co., Ltd. -0.71% -34.31%
May. 07 59,729,296 Domestic Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024. CI
May. 07 132,333,736 H Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Beijing Luzhu Biotechnology Posts Lower Loss in 2023 Amid Higher Other Income
MT
Beijing Luzhu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Beijing Luzhu Biotechnology Co., Ltd. Announces the Completion of Enrollment of Subjects for Phase III Clinical Trial of LZ901 in the PRC
CI
Beijing Luzhu Biotechnology Co., Ltd. Announces Initiation of Phase III Clinical Trial and Completion of Enrollment of First Group of Subjects for LZ901 in the PRC
CI
Beijing Luzhu Biotechnology Slashes H1 Loss
MT
Beijing Luzhu Biotechnology to Shrink H1 Loss by 87%
MT
Beijing Luzhu Biotechnology Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
CI
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs
MT
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement
CI
Beijing Luzhu Biotechnology Co., Ltd. Completes Phase II Clinical Trail in Second quarter of 2023
CI
Hong Kong Stocks Begin Week Higher; Luzhu Bio Slumps 33% in Debut
MT
Beijing Luzhu Opens 4% Lower in Hong Kong Trading Debut
MT
Beijing Luzhu Biotechnology Co., Ltd. has completed an IPO in the amount of HKD 340.6608 million.
CI
Beijing Luzhu Biotechnology Raises HK$241.6 Million in Hong Kong IPO, Prices at Bottom of Range
MT
Beijing Luzhu Biotechnology Co., Ltd. has filed an IPO in the amount of HKD 432.5769 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2480 Stock
  4. News Beijing Luzhu Biotechnology Co., Ltd.
  5. Highlights